1 asset in Viral Respiratory Tract Infection
Therapeutic assets addressing Viral Respiratory Tract Infection, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Nirsevimab Viral Respiratory Tract Infection | Menzies School of Health Research | P4 | BB (65) |